Overview

Ph II Early BC Pre-Surgical Biologic Study

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
A pre-surgery study to assess changes that occur in human breast cancer material and normal skin after a short course of treatment with Iressa.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Cancer International Research Group (CIRG)
Treatments:
Gefitinib